WuXi AppTec

WuXi AppTec (stock code: 603259. SH/2359. HK) provides comprehensive and integrated new drug research and production services for the global biopharmaceutical industry. By empowering global pharmaceutical, biotechnology, and medical device companies, WuXi AppTec is committed to driving the development of new drugs and bringing breakthrough treatment solutions to patients. Adhering to the principle of putting research first and putting customers at the center, WuXi AppTec helps customers improve their research and development efficiency through cost-effective and efficient R&D services. The service scope covers areas such as chemical drug R&D and production, cell and gene therapy R&D and production, medical device testing, etc. At present, WuXi AppTec's empowerment platform is carrying research and innovation projects from over 4100 partners from more than 30 countries around the world, committed to bringing more new and good drugs to patients worldwide, and realizing the vision of "making there no difficult drugs or diseases in the world" as soon as possible.

Visit website